Skip to main content
. 2020 Sep 30;10(59):35856–35872. doi: 10.1039/d0ra06849g

Fig. 3. (A) 3D crystal structure of the formulated vaccine construct, (B) Ramachandran plot assessment of the multi-epitope vaccine construct and (C) secondary structural analysis of the designed vaccine, showing structural atomic fluctuation within a minimal range, signifying its structural stability.

Fig. 3